4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1 H -pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.3c01424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Domiziana Masci und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of the Sacred Heart, Largo Francesco V…. Hauptthemen laut MEDLINE: Carbonic Anhydrases, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CCR NIH HHS, NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
We synthesized new pyrrole and indole derivatives as human carbonic anhydrase (hCA) inhibitors with the potential to inhibit the Wnt/β-catenin signaling pathway. The presence of both N1-(4-sulfonamidophenyl) and 3-(3,4,5-trimethoxyphenyl) substituents was essential for strong hCA inhibitors. The most potent hCA XII inhibitor 15 (Ki = 6.8 nM) suppressed the Wnt/β-catenin signaling pathway and its target genes MYC, Fgf20, and Sall4 and exhibited the typical markers of apoptosis, cleaved poly(ADP-ribose)polymerase, and cleaved caspase-3. Compound 15 showed strong inhibition of viability in a panel of cancer cells, including colorectal cancer and triple-negative breast cancer cells, was effective against the NCI/ADR-RES DOX-resistant cell line, and restored the sensitivity to doxorubicin (DOX) in HT29/DX and MDCK/P-gp cells. Compound 15 is a novel dual-targeting compound with activity against hCA and Wnt/β-catenin. It thus has a broad targeting spectrum and is an anticancer agent with specific potential in P-glycoprotein overexpressing cell lines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of the Sacred Heart, Largo Francesco Vito 1, Rome 00168, Italy.
- Laboratory Affiliated with the Institute Pasteur Italy─Cenci Bolognetti Foundation, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, Roma 00185, Italy.
- Laboratory Affiliated to Istituto Pasteur Italia─Fondazione Cenci Bolognetti, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, Rome 00161, Italy.
- Molecular Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health,…
- Department of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.
- Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Universitá degli Studi di Firenze, Via Ugo Schiff 6, Sesto Fiorentino I-50019, Firenze, Italy.
ORCID-Profile: Antonio Coluccia, Alessio Nocentini, Chiara Riganti, Claudiu T Supuran, Romano Silvestri, Giuseppe La Regina
Förderung
- CCR NIH HHS
- NCI NIH HHS
- National Cancer Institute
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Sapienza Università di Roma
- Associazione Italiana per la Ricerca sul Cancro
- Fondazione Umberto Veronesi
- Institute Pasteur Italy
Zitieren
APA
Masci, D., Puxeddu, M., Di Magno, L., D'Ambrosio, M., Parisi, A., Nalli, M., Bai, R., Coluccia, A., Sciò, P., Orlando, V., D'Angelo, S., Biagioni, S., Urbani, A., Hamel, E., Nocentini, A., Filiberti, S., Turati, M., Ronca, R., Kopecka, J., …, & La Regina, G. (2023). 4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1 H -pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01424
Vancouver
Masci D, Puxeddu M, Di Magno L, D'Ambrosio M, Parisi A, Nalli M, et al. 4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1 H -pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c01424
BibTeX
@article{Masci2023,
author = {Masci, Domiziana and Puxeddu, Michela and Di Magno, Laura and D'Ambrosio, Michele and Parisi, Anastasia and Nalli, Marianna and Bai, Ruoli and Coluccia, Antonio and Sciò, Pietro and Orlando, Viviana and D'Angelo, Sara and Biagioni, Stefano and Urbani, Andrea and Hamel, Ernest and Nocentini, Alessio and Filiberti, Serena and Turati, Marta and Ronca, Roberto and Kopecka, Joanna and Riganti, Chiara and Fionda, Cinzia and Bordone, Rosa and Della Rocca, Giorgia and Canettieri, Gianluca and Supuran, Claudiu T and Silvestri, Romano and La Regina, Giuseppe},
title = {4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1 H -pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.3c01424}
}
EUVIMED